Published in Drug Law Weekly, December 18th, 2007
"This repurchase program is the right thing to do for our shareholders and this is the right time to do it," said Dr. Leslie Hudson, Interim President and Chief Executive Officer of Nabi. "This is a first step. It not only reflects our continuing commitment to maximize shareholder value but...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.